TrialThe international journal of neuropsychopharmacology2018

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia.

Andy Forbes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.